|
SMG7 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.646240E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.283240E-03 |
| Normal-vs-Stage2 |
4.021600E-01 |
| Normal-vs-Stage3 |
7.543600E-01 |
| Normal-vs-Stage4 |
9.673800E-01 |
| Stage1-vs-Stage2 |
4.291600E-01 |
| Stage1-vs-Stage3 |
8.372300E-02 |
| Stage1-vs-Stage4 |
1.884640E-01 |
| Stage2-vs-Stage3 |
4.161800E-01 |
| Stage2-vs-Stage4 |
5.667800E-01 |
| Stage3-vs-Stage4 |
8.747800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.557600E-02 |
| Normal-vs-AfricanAmerican |
4.084400E-02 |
| Normal-vs-Asian |
1.047780E-01 |
| Caucasian-vs-AfricanAmerican |
8.132200E-01 |
| Caucasian-vs-Asian |
8.237800E-01 |
| AfricanAmerican-vs-Asian |
8.516200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.197590E-03 |
| Normal-vs-Female |
8.197800E-01 |
| Male-vs-Female |
1.080180E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.427800E-01 |
| Normal-vs-Extreme_Weight |
3.994000E-04 |
| Normal-vs-Obese |
3.023400E-01 |
| Normal-vs-Extreme_Obese |
6.217800E-03 |
| Normal_Weight-vs-Extreme_Weight |
9.358000E-02 |
| Normal_Weight-vs-Obese |
8.310600E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.341610E-01 |
| Extreme_Weight-vs-Obese |
3.444300E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.409800E-01 |
| Obese-vs-Extreme_Obese |
2.396200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.967600E-01 |
| Normal-vs-Age(41-60Yrs) |
4.218600E-01 |
| Normal-vs-Age(61-80Yrs) |
2.304000E-03 |
| Normal-vs-Age(81-100Yrs) |
1.840140E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.808000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.946010E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.281500E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.074400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.125530E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.245410E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.017700E-03 |
| Normal-VS-Type2 PRCC |
1.692030E-01 |
| Normal-VS-KIRP CIMP |
9.821400E-01 |
| Normal-VS-Unclassified PRCC |
2.417000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
7.179000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.278200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.411000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.772200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.333800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.433800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.966400E-02 |
| Normal-vs-N1 |
2.918400E-01 |
| Normal-vs-N2 |
9.772400E-01 |
| N0-vs-N1 |
3.349700E-02 |
| N0-vs-N2 |
4.255800E-01 |
| N1-vs-N2 |
3.498600E-01 |
|
|
